课题基金 / 基金详情

Transcription factor regulation of malignant cell transformation and its repression

Transcription factor regulation of malignant cell transformation and its repression
恶性细胞转化的转录因子调控及其抑制
批准号:
15027201
负责人:
YAMAMOTO Masayuki
金额:
$37.76万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

YAMAMOTO Masayuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study we have studied transcription factor regulation of malignant cell transformation and its repression exploiting hematopoietic transcription factors and leukemia as a model system. GATA-1 is essential for the development of erythroid and megakaryocytic lineages and mutations leading to the production of N-terminus truncated form GATA-1 are frequently found in the Down syndrome-related acute megakaryoblastic leukemia (AMKL-DS) patients. We found that GATA-1 gene knockdown female (GATA-1.05/X) mice frequently develop a hematopoietic disorder that resembles myelodysplastic syndrome characterized by the accumulation of progenitors. We have demonstrated that GATA-1.05/X mice suffer from two distinct types of acute leukemias. Since GATA-1 is an X chromosomal gene, two types of hematopoietic cells reside within heterozygous GATA-1 knockdown mice, bearing either an active wild-type GATA-1 allele or an active mutant GATA-1.05 allele. In the latter hematopoietic progenitors, low-level GATA-1 expression is sufficient to support survival, but not differentiation, leading to the accumulation of progenitors that are easily targeted by oncogenic stimuli. Since such leukemia cases have not been observed in GATA-1-null/X mutant mice and since transgenic expression of wild-type GATA-1 rescue GATA-1.05/X mice from the leukemia, we conclude that the residual GATA-1 activity in the knockdown mice contributes to the development of the malignancy. In addition, wild-type GATA-1 promoted AMKL-DS leukemic cells to mature erythroid cells, but truncated form GATA-1 could not, suggesting that defect of GATA-1 is one of the leukemogenic factors.
期刊论文(458)
专著(0)
科研奖励(0)
会议论文
Function of GATA transcription factors in the induction of endothelial VCAM-1 by TNF-α.
GATA 转录因子在 TNF-α 诱导内皮 VCAM-1 中的功能。
DOI: --
发表时间: 2001
期刊: Arterioscler. Thromb. Vasc. Biol. 21
影响因子: --
作者: [Umetani, M., et al.]
通讯作者: et al.
Positive regulation by GATA-1 of GATA-1 gene hematopoietic regulatory domain in zebrafish embryos in vivo.
GATA-1对斑马鱼胚胎体内GATA-1基因造血调节域的正向调节作用。
DOI: --
发表时间: 2001
期刊: Development 128
影响因子: --
作者: [Kobayashi, M., et al.]
通讯作者: et al.
Hemin-induced activation of the Thioredoxin gene by Nrf2 : a differential regulation of the antioxidant responsive element (ARE) by switch of its binding factors.
Nrf2 血红素诱导的硫氧还蛋白基因激活:通过切换其结合因子对抗氧化反应元件 (ARE) 进行差异调节。
DOI: --
发表时间: 2001
期刊: J. Biol. Chem. 276
影响因子: --
作者: [Kim, Y-C., et al.]
通讯作者: et al.
Xu, G, Nagano, M: "Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down' s syndrome"Blood. 102. 2960-2968 (2003)
Xu, G, Nagano, M:“唐氏综合症短暂性骨髓增生性疾病中 GATA-1 基因的频繁突变”血液。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
132
    視覚と触覚のリアリティを考えた溶接教育シミュレーターの開発
    • 批准号:
      22H04141
    • 项目类别:
      Grant-in-Aid for Encouragement of Scientists
    • 资助金额:
      $0.31万
    • 财政年份:
      2022
    • 负责人:
      YAMAMOTO Masayuki
    • 依托单位:
    仮想的に溶接技術を体験できるオンライン教育支援システムの開発
    • 批准号:
      21H04029
    • 项目类别:
      Grant-in-Aid for Encouragement of Scientists
    • 资助金额:
      $0.3万
    • 财政年份:
      2021
    • 负责人:
      YAMAMOTO Masayuki
    • 依托单位:
    Elucidation of the lignan biosynthesis pathway in sesame seeds.
    • 批准号:
      18K05571
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2018
    • 负责人:
      YAMAMOTO Masayuki
    • 依托单位:
    Identification of genes controlling the contents of sesame seed lignans
    • 批准号:
      25450003
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      YAMAMOTO Masayuki
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: